Cargando…
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
BACKGROUND: In this study, we aimed to evaluate the factors that contribute to survival outcomes in patients with thymoma treated with multimodal approaches. METHODS: A total of 203 patients (105 males, 98 females; median age: 49 years; range, 17 to 77 years) with Masaoka-Koga Stage II-IV thymoma be...
Autores principales: | Ak, Naziye, Toker, Alper, Kara, Murat, Özkan, Berker, Ülker, Melike, Kaba, Erkan, Yeğen, Gülçin, Karaman, Şule, Dağoğlu, Nergiz, Kaytan Sağlam, Esra, Oral, Ethem Nezih, Kızır, Ahmet, Bayraktar, Soley, Dişçi, Rian, Ferhatoğlu, Ferhat, Aydın, Esra, Vatansever, Sezai, Eralp, Yeşim, Aydıner, Adnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bayçınar Medical Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762900/ https://www.ncbi.nlm.nih.gov/pubmed/35096446 http://dx.doi.org/10.5606/tgkdc.dergisi.2021.20529 |
Ejemplares similares
-
Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016) -
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study
por: Gural, Zeynep, et al.
Publicado: (2018) -
The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV(max) on Predicting Survival in Patients with Rectal Cancer
por: Alçın, Göksel, et al.
Publicado: (2020) -
Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases
por: Dagoglu, Nergiz, et al.
Publicado: (2019) -
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study
por: SENYUREK, SUKRAN, et al.
Publicado: (2023)